Log in | Register

Corticosteroids in pediatric ARDS: all cards on the table

Andreas Schwingshackl| Gianfranco Umberto Meduri| Dai Kimura| Stephania A. Cormier| Kanwaljeet J. S. Anand
Correspondence
Volume 41, Issue 11 / November , 2015

Pages 2036 - 2037

No abstract available.

References

  1. Yehya N, Servaes S, Thomas NJ, Nadkarni VM, Srinivasan V (2015) Corticosteroid exposure in pediatric acute respiratory distress syndrome. Intensive Care Med. doi:10.1007/s00134-015-3953-4
    • View reference on PubMed
  2. Peters MJ, Ray S, Kneyber M (2015) Corticosteroids for paediatric ARDS: unjustified—even unjustifiable? Intensive Care Med. doi:10.1007/s00134-015-3963-2
  3. Confalonieri M, Urbino R, Potena A, Piattella M, Parigi P, Puccio G, Della Porta R, Giorgio C, Blasi F, Umberger R, Meduri GU (2005) Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med 171:242–248
    • View reference on publisher's website
    • View reference on PubMed
  4. Meduri GU, Annane D, Chrousos GP, Marik PE, Sinclair SE (2009) Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy. Chest 136:1631–1643
    • View reference on publisher's website
    • View reference on PubMed
  5. Drago BB, Kimura D, Rovnaghi CR, Schwingshackl A, Rayburn M, Meduri GU, Anand KJ (2015) Double-blind, placebo-controlled pilot randomized trial of methylprednisolone infusion in pediatric acute respiratory distress syndrome. Pediatr Crit Care Med 16:e74–e81
    • View reference on publisher's website
    • View reference on PubMed

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement